BioSpace News Archive

Biotech Beach

Large Prospective Trial Validates Detection of AR-V7 Biomarker Using Epic Sciences’ Platform to Predict Treatment Outcomes for Patients with Advanced Prostate Cancer

PROPHECY validation trial published in Journal of Clinical Oncology

March 13, 2019
·
6 min read
Business

VolitionRx Limited Announces Full Fiscal Year 2018 Financial Results and Business Update

Conference call to discuss financial and operational results scheduled for Thursday, March 14 at 8:30 a.m. U.S. Eastern Time

March 13, 2019
·
9 min read
Business

Sophiris Bio Reports Fourth Quarter 2018 and Year-end Financial Results and Recent Corporate Highlights

Sophiris Bio is a first-in-class, pore-forming protein, in late-stage clinical trials for the treatment of patients with urological diseases

March 13, 2019
·
12 min read
BioForest

Viking Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update

Conference call scheduled for 4:30 p.m. ET today

March 13, 2019
·
13 min read
Business

CTI BioPharma Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Highlights

The Company is focused on advancing its development program of pacritinib for the treatment for myelofibrosis patients with severe thrombocytopenia in the United States and Europe in 2019

March 13, 2019
·
7 min read
Business

Apyx Medical Corporation Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Introduces Fiscal Year 2019 Outlook

Advanced Energy Sales increase 40% year-over-year in Q4 and increase 71% year-over-year in FY’18

March 13, 2019
·
18 min read
Business

Second Sight Reports Fourth Quarter and Full Year 2018 Financial Results

Second Sight Medical Products is a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals

March 13, 2019
·
15 min read
Drug Development

Santhera Completes Patient Enrollment in Phase IV Long-term Study with Raxone® for the Treatment of Leber’s Hereditary Optic Neuropathy

Results from the 24-month active treatment study conducted in 31 study centers in Europe and the USA are expected in 2021.

March 13, 2019
·
5 min read
Business

Oxford Biomedica announces R&D collaboration with Microsoft to improve gene and cell therapy manufacturing using the intelligent cloud and machine learning

Cell and gene therapy has the potential to transform medicine, providing long-term and potentially curative treatment options for a wide range of diseases.

March 13, 2019
·
4 min read
Linkam launches new addition to their humidity control system with support for nitrogen gas.

The RH95 Relative Humidity Controller provides precise environmental sample control to Linkam’s range of temperature stages

March 13, 2019
·
3 min read